University of Cincinnati Launches Peptide Antimicrobial Clinical Trial for Prosthetic Joint Infections
UC launched a clinical trial using Peptilogics' peptide-based antimicrobial agent to treat prosthetic joint infections by targeting bacterial biofilms that have resisted traditional therapies.